Achilles Therapeutics PLC Stock Forecast, Predictions & Price Target

Analyst price target for ACHL

Based on 2 analysts offering 12 month price targets for Achilles Therapeutics PLC.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell ACHL stock?

Based on 2 analysts offering ratings for Achilles Therapeutics PLC.
Strong Buy
Strong Buy
2 analysts 100%
0 analysts 0%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACHL stock forecasts and price targets.

ACHL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Chardan Capital
Top 20%
Strong BuyMaintains$17.00+1,831.82%2022-12-07
Piper Sandler
Bottom 9%
Strong BuyMaintains$8.00+809.09%2022-12-07

1 of 1

ACHL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACHL$0.88$12.50+1,320.45%Strong Buy
CKPT$3.82$45.50+1,091.10%Strong Buy
TNXP$0.56$6.50+1,060.71%Strong Buy

Achilles Therapeutics Stock Forecast FAQ

Is Achilles Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ACHL) stock is to Strong Buy ACHL stock.

Out of 2 analysts, 2 (100%) are recommending ACHL as a Strong Buy, 0 (0%) are recommending ACHL as a Buy, 0 (0%) are recommending ACHL as a Hold, 0 (0%) are recommending ACHL as a Sell, and 0 (0%) are recommending ACHL as a Strong Sell.

If you're new to stock investing, here's how to buy Achilles Therapeutics stock.

What is ACHL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ACHL price target, the average ACHL price target is $12.50, with the highest ACHL stock price forecast at $17.00 and the lowest ACHL stock price forecast at $8.00.

On average, Wall Street analysts predict that Achilles Therapeutics's share price could reach $12.50 by Dec 7, 2023. The average Achilles Therapeutics stock price prediction forecasts a potential upside of 1,320.45% from the current ACHL share price of $0.88.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.